4.5 Article

Array-based comparative genomic hybridization and immunohistochemical studies in gliomatosis cerebri

Journal

JOURNAL OF NEURO-ONCOLOGY
Volume 90, Issue 3, Pages 259-266

Publisher

SPRINGER
DOI: 10.1007/s11060-008-9665-7

Keywords

Gliomatosis cerebri; Array-based comparative genomic hybridization; Immunohistochemistry

Funding

  1. Seoul National University Hospital [04-2007-058-0]

Ask authors/readers for more resources

Gliomatosis cerebri (GC) are extensively infiltrative glial tumors classified as astrocytic tumors in the current World Health Organization (WHO) classification scheme. In investigating the tumorigenesis of GC, we reviewed 28 cases of GC immunohistochemically and carried out array-based comparative genomic hybridization (CGH) in ten of those cases. In histological and immunohistochemical review, 18 cases (64%) were of astrocytic lineage, three (11%) were of oligodendroglial lineage, and seven (25%) were of uncommitted lineage. In the array-based CGH, 52 clones were frequently lost on 6p, 9p, and 9q in more than six cases, and six clones were frequently gained on 1p, 6q, 10q, and 21q in more than three cases. Some gained or lost genetic loci differed significantly between the histologically high-grade and low-grade GC (P < 0.05), but unsupervised hierarchical clustering failed to produce evidence of any clinical significance. These altered genetic foci are not known to be involved in the development of conventional glial tumors, including astrocytic tumors. In conclusion, despite the dominant astrocytic differentiation of GC histologically, novel genomic aberrations found in our GC cases were different from those of astrocytic tumors.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Letter Clinical Neurology

ZFTA-YAP1 fusion-positive ependymoma can occur in the spinal cord: Letter to the editor

Ka Young Lim, Kwang Hoon Lee, Ji Hoon Phi, Hongseok Yun, Jae Kyung Won, Seung Hong Choi, Sung-Hye Park

BRAIN PATHOLOGY (2022)

Article Clinical Neurology

Retained medullary cord and terminal myelocystocele as a spectrum: case report

Youngbo Shim, Hyun Joo Park, Kyung Hyun Kim, Sung-Hye Park, Kyu-Chang Wang, Ji Yeoun Lee

Summary: This study found that the medullary cord in humans typically degenerates during development, leading to anomalies such as terminal myelocystocele (TMCC) and retained medullary cord (RMC). A 1-month-old boy was identified with features of both TMCC and RMC, providing clinical evidence that they share the same pathoembryogenic origin.

CHILDS NERVOUS SYSTEM (2022)

Review Oncology

Emerging glioneuronal and neuronal tumors: case-based review

So Dug Lim, Seong Ik Kim, Jin Woo Park, Jae Kyung Won, Seung-Ki Kim, Ji Hoon Phi, Chun-Kee Chung, Seung-Hong Choi, Hongseok Yun, Sung-Hye Park

Summary: This article provides a thorough analysis of three rare central nervous system tumors, describing their characteristics and diagnostic methods.

BRAIN TUMOR PATHOLOGY (2022)

Article Biology

Genome-wide perturbations of Alu expression and Alu-associated post-transcriptional regulations distinguish oligodendroglioma from other gliomas

Taeyoung Hwang, Sojin Kim, Tamrin Chowdhury, Hyeon Jong Yu, Kyung-Min Kim, Ho Kang, Jae-Kyung Won, Sung-Hye Park, Joo Heon Shin, Chul-Kee Park

Summary: The study reveals that Alu element-associated post-transcriptional processes and RNA expression are decreased in gliomas, with grade 2 oligodendrogliomas showing the least perturbation in A-to-I editing and circular RNA levels. This provides further insight into gliomagenesis from the perspective of Alu repeat elements.

COMMUNICATIONS BIOLOGY (2022)

Article Clinical Neurology

Toxic leukoencephalopathy with axonal spheroids caused by chemotherapeutic drugs other than methotrexate

Ka Young Lim, Seong-Ik Kim, Hyunhee Kim, Jeongwan Kang, Jin Woo Park, Jae Kyung Won, Dong-Yeop Shin, Sung-Hye Park

Summary: This report describes two cases that confirm the clinicopathological features of chemotherapy-induced toxic leukoencephalopathy, emphasizing that chemotherapy drugs other than methotrexate can also cause this disease.

BMC NEUROLOGY (2022)

Article Oncology

Validation of MRI-Based Models to Predict MGMT Promoter Methylation in Gliomas: BraTS 2021 Radiogenomics Challenge

Byung-Hoon Kim, Hyeonhoon Lee, Kyu Sung Choi, Ju Gang Nam, Chul-Kee Park, Sung-Hye Park, Jin Wook Chung, Seung Hong Choi

Summary: Recent studies have shown promising results in using MRI to predict MGMT methylation status in gliomas. However, the diagnostic performance of these prediction models was not reproducible when using larger datasets. To our knowledge, there has been no study regarding the external validation of MGMT prediction models using large-scale multicenter datasets.

CANCERS (2022)

Article Rehabilitation

Low-Frequency Repetitive Transcranial Magnetic Stimulation in the Early Subacute Phase of Stroke Enhances Angiogenic Mechanisms in Rats

Yookyung Lee, Byung-Mo Oh, Sung-Hye Park, Tai Ryoon Han

Summary: This study found that low-frequency rTMS of the ipsilesional hemisphere in the early subacute phase of stroke promotes the expression of angiogenic factors and related genes in the brain, particularly in the injured area.

ANNALS OF REHABILITATION MEDICINE-ARM (2022)

Article Clinical Neurology

MYB/MYBL1::QKI fusion-positive diffuse glioma

Ye Yoon Suh, Kwanghoon Lee, Yu-Mi Shim, Ji Hoon Phi, Chul-Kee Park, Seung-Ki Kim, Seung Hong Choi, Hongseok Yun, Sung-Hye Park

Summary: The MYB/MYBL1::QKI fusion activates the oncogene MYB and deletes the tumor suppressor gene QKI. Previously, this fusion was only reported in angiocentric glioma (AG) and diffuse low-grade glioma. This study compares two tumors with the MYB/MYBL1::QKI fusion: a diffuse pediatric-type high-grade glioma (DPedHGG) in an 11-year-old boy and an AG in a 46-year-old woman. Characterization using immunohistochemistry, next-generation sequencing, and methylation profiling reveals their molecular characteristics and supports the presence of MYB/MYBL1 alterations in higher-grade gliomas.

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2023)

Article Pediatrics

Twenty-Year Retrospective Study of Post-Enucleation Chemotherapy in High-Risk Patients with Unilateral Retinoblastoma

Yoon Sunwoo, Jung Yoon Choi, Hyun Jin Park, Bo Kyung Kim, Kyung Taek Hong, Sang In Khwarg, Jaemoon Koh, Sung-Hye Park, Dong Hyun Jo, Jeong Hun Kim, Jung-Eun Cheon, Hyoung Jin Kang

Summary: This study presents the treatment outcomes of patients with unilateral retinoblastoma who received primary enucleation and adjuvant chemotherapy. The overall survival rate was 100% and the event-free survival rate was 95%. Treatment with chemotherapy was well tolerated with minimal toxicity. However, further research is needed on risk stratification and treatment intensity.

CHILDREN-BASEL (2022)

Editorial Material Clinical Neurology

Announcing the Asian Oceanian Society of Neuropathology guidelines for Adapting Diagnostic Approaches for Practical Taxonomy in Resource-Restrained Regions (AOSNP-ADAPTR)

M. E. Buckland, C. Sarkar, V. Santosh, M. Al-Hussaini, S. H. Park, T. Tihan, H. K. Ng, T. Komori

BRAIN PATHOLOGY (2023)

Article Clinical Neurology

Fibrous hamartoma of infancy of the spinal cord resembling conus and filum, with a coexisting sacral dimple

Tae-Hwan Park, Kyung Hyun Kim, Seung-Ki Kim, Kyu-Chang Wang, Sung-Hye Park, Ji Yeoun Lee

Summary: Fibrous hamartoma of infancy (FHI) is a rare benign soft tissue lesion that usually occurs in infants and young children within the first 2 years of life. FHI in the central nervous system (CNS) is extremely rare, with only two cases of spinal cord FHI reported so far. We present a unique case of FHI in a 1-month-old girl with a skin dimple in the coccygeal area, where both a skin lesion and an intramedullary mass were diagnosed as FHI. Despite being diagnosed with a neurogenic bladder, the patient maintained normal neurological function and showed good mobility during the 5.5-year follow-up period.

CHILDS NERVOUS SYSTEM (2023)

Review Clinical Neurology

Neuroepithelial tumor with EWSR1::PATZ1 fusion: A literature review

Hyunhee Kim, Kwanghoon Lee, Ji Hoon Phi, Sun Ha Paek, Hongseok Yun, Seung Hong Choi, Sung-Hye Park

Summary: This study presents the clinicopathological and molecular genetic characteristics of a neuroepithelial tumor (NET) with EWSR1::PATZ1 fusion, which has recently been discovered in rare central nervous system tumors and soft tissue sarcomas. Two cases of this fusion were identified, with the pediatric case showing a high-grade tumor and longer survival compared to conventional glioblastoma. The TERT promoter mutation may serve as an indicator of high-grade behavior in PATZ1 fusion NET.

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2023)

Article Medicine, Research & Experimental

Epigenetic Alteration of H3K27me3 as a Possible Oncogenic Mechanism of Central Neurocytoma

Hyunhee Kim, Kwanghoon Lee, Yu -Mi Shim, Eric Eunshik Kim, Seung-Ki Kim, Ji Hoon Phi, Chul-Kee Park, Seung Hong Choi, Sung-Hye Park

Summary: Central neurocytoma is a low-grade neuronal tumor that mainly occurs in the lateral ventricle, and the genetic abnormalities that cause this tumor are poorly understood. Through the study of immunomarkers in fetal and adult brains, as well as supratentorial periventricular tumors, the biomarkers, cell of origin, and tumorigenesis of central neurocytoma were characterized. Immunohistochemical analysis showed that central neurocytomas were positive for certain markers, including FGFR3, SSTR2, TTF-1, GLUT-1, and L1CAM.

LABORATORY INVESTIGATION (2023)

Article Biochemistry & Molecular Biology

Enrichment of Deleterious Mutated Genes Involved in Ciliary Function and Histone Modification in Brain Cancer Patient-Derived Xenograft Models

Hyeongsun Jeong, Hyo Eun Moon, Seongmin Yun, Seung Woo Cho, Hye Ran Park, Sung-Hye Park, Kyungjae Myung, Taejoon Kwon, Sun Ha Paek

Summary: In this study, 13 PDX models derived from 11 brain tumor patients were established. It was found that PDX samples were enriched with brain tumor-related genes and had distinct mutation profiles compared to the original tumors, indicating mutational alterations occurring in the xenograft environment.

BIOMEDICINES (2023)

Review Medicine, General & Internal

Brain Tumor Classification by Methylation Profile

Jin Woo Park, Kwanghoon Lee, Eric Eunshik Kim, Seong-Ik Kim, Sung-Hye Park

Summary: The methylation classifier is a tool used to accurately classify brain tumors based on their methylation profiles. It helps healthcare professionals predict tumor prognosis and establish personalized treatment plans. However, it has limitations in classifying all types of brain tumors and faces challenges in obtaining reference data and charging patients for its services.

JOURNAL OF KOREAN MEDICAL SCIENCE (2023)

No Data Available